Stock Research for GENE


Featured Broker: Ally Invest

Get the due diligence for another stock.


GENE Stock Chart & Research Data

The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


GENE Due diligence Resources & Stock Charts

The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GENE Detailed Price Forecast - CNN Money CNN View GENE Detailed Summary - Google Finance
Yahoo View GENE Detailed Summary - Yahoo! Finance Zacks View GENE Stock Research & Analysis -

Stock Analysis

TradeIdeas View GENE Trends & Analysis - Trade-Ideas Barrons View GENE Major Holders - Barrons
NASDAQ View GENE Call Transcripts - NASDAQ Seeking View GENE Breaking News & Analysis - Seeking Alpha
Spotlight View GENE Annual Report - OTC Report View GENE OTC Short Report -
TradeKing View GENE Fundamentals - TradeKing Charts View GENE SEC Filings - Bar Chart
WSJ View Historical Prices for GENE - The WSJ Morningstar View Performance/Total Return for GENE - Morningstar
MarketWatch View the Analyst Estimates for GENE - MarketWatch CNBC View the Earnings History for GENE - CNBC
StockMarketWatch View the GENE Earnings - StockMarketWatch MacroAxis View GENE Buy or Sell Recommendations - MacroAxis
Bullish View the GENE Bullish Patterns - American Bulls Short Pains View GENE Short Pain Metrics -

Social Media Mentions

StockTwits View GENE Stock Mentions - StockTwits PennyStocks View GENE Stock Mentions - PennyStockTweets
Twitter View GENE Stock Mentions - Twitter Invest Hub View GENE Investment Forum News - Investor Hub
Yahoo View GENE Stock Mentions - Yahoo! Message Board Seeking Alpha View GENE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for GENE - Insider Cow View Insider Transactions for GENE - Insider Cow
CNBC View GENE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GENE - OTC Markets
Yahoo View Insider Transactions for GENE - Yahoo! Finance NASDAQ View Institutional Holdings for GENE - NASDAQ

Stock Charts

FinViz View GENE Stock Insight & Charts - StockCharts View GENE Investment Charts -
BarChart View GENE Stock Overview & Charts - BarChart Trading View View GENE User Generated Charts - Trading View

Latest Financial News for GENE

Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres
Posted on Friday February 01, 2019

MELBOURNE, Australia, Feb. 01, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the.

Genetic Technologies Limited Provides End of Year Update on the Test Development Program
Posted on Friday December 21, 2018

Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, provides today an update on its R&D program for the year. As announced to the market on 16th March 2018, Genetic Technologies Limited has embarked on a collaborative research program with academic research staff from the Centre for Epidemiology and Biostatistics at The University of Melbourne. Led by Professor John Hopper, the research is designed to broaden the applicability of the BREVAGenplus® breast cancer risk assessment test enabling its use in women with an extended family history of disease and will also increase the range of risk factors analysed.

Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture
Posted on Thursday December 20, 2018

MELBOURNE, Australia, Dec. 20, 2018 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), via its subsidiary Gene Ventures Pty Ltd, is pleased to announce that.

Today’s Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals
Posted on Tuesday July 17, 2018

NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Genetic Technologies saw big gains on news that its breast cancer and colorectal cancer risk assessment tests are on track. Shares of Innovate were headed in the opposite direction on news that the company has filed a securities registration statement amendment with the SEC to issue up to $175 million of new stock and to sell 14 million shares of existing stock. Innovate Biopharmaceuticals, Inc.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.